← Back to Clinical Trials
Recruiting NCT07390188

NCT07390188 Prevalence of Oral Mucosal Lesions Among a Sample of Adult Egyptian Subjects

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07390188
Status Recruiting
Phase
Sponsor Cairo University
Condition Oral Mucosal Disease
Study Type OBSERVATIONAL
Enrollment 14,645 participants
Start Date 2025-07-08
Primary Completion 2026-04-30

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 14,645 participants in total. It began in 2025-07-08 with a primary completion date of 2026-04-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Oral mucosal lesion represents a wide array of conditions. They may be the result of a local or systemic infection or trauma or the manifestations of a medical condition or neoplastic growth weather primary or metastatic or may be mistaken for a variation of a normal structure. This study aims to estimate the prevalence of OMLs and describe the risk factors for the development of OMLs in a sample of the Egyptian population Research Question :What is the prevalence of oral mucosal lesions and their associated risk factors in a sample of adult Egyptians?

Eligibility Criteria

Inclusion Criteria: * Adults, 18 years old and above, Egyptian individuals Exclusion Criteria: * Individuals refusing to participate in the study. Individuals unable to give accurate or full information due to suffering from acute symptoms, requiring immediate intervention. Individuals unable to give accurate or full information due to any disease preventing them from opening their mouth.

Contact & Investigator

Central Contact

Eslam El Zayat, BSC of Oral & Dental Medicine

✉ eslam.elzayat@dentistry.cu.edu.eg

📞 +201062630864

Frequently Asked Questions

Who can join the NCT07390188 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Oral Mucosal Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07390188 currently recruiting?

Yes, NCT07390188 is actively recruiting participants. Contact the research team at eslam.elzayat@dentistry.cu.edu.eg for enrollment information.

Where is the NCT07390188 trial being conducted?

This trial is being conducted at Cairo, Egypt.

Who is sponsoring the NCT07390188 clinical trial?

NCT07390188 is sponsored by Cairo University. The trial plans to enroll 14,645 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology